MedPath

The efficacy of the administration of SGLT-2 inhibitor and/or DPP-4 inhibitor in type 2 diabetic patient with basal-bolus insulin therapy.

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000020742
Lead Sponsor
Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Type 1 diabetes renal dysfunction hepatic dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath